Skip to main content

Day: December 3, 2021

GeoVax Presents Hemorrhagic Fever Vaccine Data at the World Vaccine & Immunotherapy Congress

Nonhuman Primate Testing of Sudan and Marburg Vaccine Candidates Demonstrates Efficacious Immune Response ATLANTA, GA, Dec. 03, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, presented data from ongoing studies of its investigational vaccines against hemorrhagic fevers (Sudan, Ebola, & Marburg) at the recent World Vaccine & Immunotherapy Congress, held November 30 – December 2 in San Diego, California. The presentation, titled “Design and Evaluation of Vaccines Against Hemorrhagic Fevers using the MVA-VLP Platform”, was delivered by Mary Hauser, PhD, GeoVax Senior Scientist. In her talk, Dr. Hauser discussed the preclinical efficacy of GeoVax’s vaccines against Sudan (SUDV) and Marburg (MARV)...

Continue reading

RENNOVA HEALTH, INC. OWNED HOSPITAL RECEIVES CRITICAL ACCESS HOSPITAL CERTIFICATION

WEST PALM BEACH, Fla., Dec. 03, 2021 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA) today announced that the application by its hospital, Scott County Community Hospital, Inc. (DBA Big South Fork) in Oneida, TN, for designation as a Critical Access Hospital (CAH) has been approved by Centers for Medicare and Medicaid Services (CMS). The effective date of approval is retrospective to June 30, 2021. CAH status means the hospital will be entitled to a cost-based reimbursement from Medicare, which has the potential to increase revenue. There are a number of benefits of CAH including that capital improvement costs are included in allowable costs for determining Medicare reimbursement. This special reimbursement that CAHs receive is intended to improve their financial performance and thereby maintain access to basic health care...

Continue reading

Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.38 per Share

ANCHORAGE, Alaska, Dec. 03, 2021 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.38 per share. The dividend will be payable on December 23, 2021, to shareholders of record at the close of business on December 16, 2021. “We are committed to providing returns to our shareholders through consistent quarterly cash dividends,” said Joe Schierhorn, President and CEO. At the stock price of $44.30 per share at the close of the market on December 2, 2021, the current dividend equates to a yield of 3.43% on an annualized basis. October 29, 2021, Northrim reported net income of $8.88 million, or $1.42 per diluted share, in the third quarter of 2021, compared to $8.35 million, or $1.33 per diluted share, in the second quarter of 2021, and...

Continue reading

Victory Square Technologies To Issue Second Tranche of Special Common Share Dividend of its Interest in Portfolio Company Fantasy 360 Technologies Inc. in December 2021

Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 03, 2021 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square” or “VST” or “Company”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce that, further to its news release dated August 12, 2021, the company will issue the second tranche of its previously announced special dividend of common shares in the capital of its portfolio company Fantasy 360 Technologies Inc. (“Immersive”) to shareholders of Victory Square in December 2021. The second tranche will consist of approximately an additional 4,500,000 Immersive Shares which will be eligible to Victory Square shareholders of record as of a date to be determined by Victory Square. Victory Square already Issued a special common share...

Continue reading

SCYNEXIS Reports the Exercise of Warrants Totalling $7.9 Million

JERSEY CITY, N.J., Dec. 03, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported the exercise of warrants to purchase 1.2 million shares of SCYNEXIS common stock by Federated Hermes Kaufmann Small Cap Fund and Dafna Lifescience LP for which SCYNEXIS accepted a reduced exercise price. Proceeds to SCYNEXIS are approximately $7.9 million. The exercised warrants were issued in SCYNEXIS’s December 2019 financing. The remaining warrants issued in the December 2019 financing covering approximately 3.2 million shares of common stock expired unexercised on December 2, 2021. “We believe the exercise of warrants by two of our largest stockholders provides a significant sign of confidence in the...

Continue reading

AiXin Life International, Inc. (OTCQX: AIXN) Launches Antibacterial Product to Facilitate Prevention and Control of Covid-19

CHENGDU, CHINA, Dec. 03, 2021 (GLOBE NEWSWIRE) — AiXin Life International, Inc. (OTCQX: AIXN) (hereinafter referred to as “AIXN” or the “Company”), a Company that specializes in providing nutritional products to the Chinese market as well as advertising and marketing services to distributors, today announced that it jointly hosted the launch of a new anti-bacterial agent, with this product being unveiled at the Chengdu AiXin Shangyan Hotel in November 2021.AIXN Chairman & CEO Mr. Quanzhong LinIn the current pandemic situation, companies and governments work together to contribute to the prevention and elimination of Covid-19, and help economies resume work and production. AIXN, in collaboration with various government scientific research institutions and enterprises, jointly hosted the “Zhongyixin Antimicrobial...

Continue reading

Form 8 (OPD) Invesco Ltd. Form 8.3 Clinigen Group Plc

Opening Position Disclosure FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Clinigen Group Plc  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the...

Continue reading

Patriot Glass Solutions, a Division of C-Bond Systems, Receives Purchase Order Through One of its Premier Distributors for C-Bond Ballistic-Resistant System for Fortune 500 Customer in San Francisco Bay Area

Orders Like This Highlight the Increasing Need for Security Solutions like C-Bond BRS to Help Prevent Break-ins, Smash-and-Grab Robberies, Looting, and Gunfire HOUSTON, Dec. 03, 2021 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, announced today that its Patriot Glass Solutions division received a purchase order through one of its premier distributors for C-Bond BRS (ballistic-resistant system) for a Fortune 500 customer in the San Francisco Bay Area. The customer is installing C-Bond BRS at its corporate headquarters. Patriot Glass Solutions’ leading products are C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a multi-purpose glass strengthening primer and window film mounting solution that deters forced entry. “This Fortune 500 customer is taking...

Continue reading

Validation Process Commences for Mullen’s Class 2 EV Cargo Vans

Initial validation and assessment for Class 2 cargo vans has begun at AMEC facility outside Tunica, Mississippi. Company on track with Q2 2022 deliveries for fleet order customers.Mullen Begins Class @ EV Cargo Van Validation ProcessClass 2 EV Cargo Van begins validation process at AMEC Facility in Tunica, Mississippi.BREA, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an emerging electric vehicle (“EV”) manufacturer, today announces that initial validation testing of the Class 2 EV cargo van has begun at Mullen’s Advanced Manufacturing and Engineering Center (AMEC) in Tunica, Mississippi.     Mullen’s Class 2 EV cargo van (ONE®) is based on a 144-inch wheelbase, 78.8-kWh battery pack, rear-wheel drive and modular 460-cubic-foot...

Continue reading

Harbor Custom Development, Inc. Contracts to Acquire 997-Unit Master Planned Community in Vancouver, BC Metro Market for $14,000,000

Gig Harbor, Washington , Dec. 03, 2021 (GLOBE NEWSWIRE) — Harbor Custom Development, Inc. (Nasdaq: HCDI, HCDIP, HCDIW, HCDIZ) (“Harbor,” “Harbor Custom Homes®,” or the “Company”), an innovative and market leading real estate company involved in all aspects of the land development cycle, today announced that it has entered into a contract to acquire Grandis Pond, a 438-acre master-planned community in Blaine, Washington on the Washington/Canadian border for $14,000,000. Grandis Pond is the largest project Harbor has contracted for purchase to date and will nearly double the Company’s current inventory by adding a mix of residential housing with up to 997 single and multi-family housing units and approximately 48,000 square feet of neighborhood commercial space. The project is located 33 miles from downtown Vancouver, British Columbia,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.